期刊文献+

基质金属蛋白酶-2的表达及微血管密度与宫颈癌侵袭性的相关性 被引量:6

The expression of MMP-2 and the value of MVD in invasive cervical carcinoma
下载PDF
导出
摘要 目的:研究宫颈癌组织中基质金属蛋白酶-2(MMP-2)的表达及微血管密度(MVD)与宫颈癌侵袭转移的相关关系。方法:采用免疫组化SP法,分别测定12例正常宫颈组织、14例宫颈原位癌、56例宫颈浸润癌组织中MMP-2的表达及MVD值。结果:宫颈癌中,MMP-2主要表达于细胞浆和/或细胞膜,CD34主要表达于间质血管内皮细胞。宫颈浸润癌MMP-2表达明显高于宫颈原位癌和正常宫颈组织,宫颈浸润癌组织MVD与宫颈原位癌和正常宫颈组织比较,有显著统计学差异(P=0.000)。MMP-2及MVD与临床分期、组织学类型、细胞分化程度及淋巴结转移均有一定关系。结论:MMP-2在宫颈癌的浸润和转移中发挥了重要作用,MVD值增高与肿瘤进展有密切关系,可作为观察宫颈癌进展的重要指标。 Objective :To study the expression of matrix metalloproteinase - 2 ( MMP - 2) and microvessel density (MVD) in cervical cancer and their correlation with clinic -pathologic features. Methods: The expression of MMP -2 and MVD was detected by immunothistochemical method in 12 NCE cases, 14 CIS cases and 56 ICC cases. Resuits: MMP -2 protein was expressed in membrane and/or cytolymph, CD34 was expressed in vascular endothehal ceil of stromal. Compared to those in CIS and NCE, the expression of MMP - 2 in ICC was significant higher. Compared to those in CIS and NCE, the MVD in ICC was significant higher. The expression of MMP - 2 and the value of MVD were associated with clinical stage, histological types, cell differentiation and lymph node metastasis. Conclusion: The expression of MMP -2 and the value of MVD maybe have key roles in progression of cervical cancer, and acted as indexes in cervical cancer.
出处 《现代肿瘤医学》 CAS 2008年第2期262-265,共4页 Journal of Modern Oncology
基金 泸州医学院基金资助项目(编号:06120)
关键词 宫颈癌 基质金属蛋白酶-2 微血管密度 肿瘤转移 免疫组织化学 cervival cancer matrix metalloproteinase - 2 microvessel density tumor metastasis immunohistochemistry
  • 相关文献

参考文献12

  • 1Talvensaari A,Apaja - Sarkkinen M,Hiyhtya M,et al. Martrix metalloproteinases 2 immunoactive protein appears early in cervical epithelial dedifferentiation [ J ]. Gynecol Oncol, 1999,72:306-311.
  • 2Kawano N, Osawa H, ho T, et al. Expression of gelatinase A, tissue inhibitor of metalloproteinases - 2, matrilysin, and trypsin (ogen) in lung neoplasms : An immunohistochemical study [ J ]. Human Pathol, 1997,28 (5) :614.
  • 3Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis:a new significant and independent prognostic indicator in early stage breast carcinoma [J]. J Natl Cancer Inst, 1992, 84(24) :1875-1887.
  • 4Parkin DM. Global cancer statistics in the year 2000 [ J ]. Lancet Oncol, 2001,2 ( 9 ) :533-543.
  • 5Nair SA, Nair MB,Jaynpraush PG,et al. The basement membrane and tumor progression in the uterine cervix[J]. Gen Diagn Pathol, 1997,142(2-5):297-303.
  • 6Goldberg I, Davidson B, Leme -Geva L, et al. Expression of extracellular matrix proteins in cervical squamous cell carcinoma——a clinicopathological study[J] . J Clin Pathol, 1998,51 (10) :781-785.
  • 7Davidson B, Goldberg I, Kopoloric J, et al. Expression of matrix metalloproteinase - 9 in squamous cell carcinoma of the uterine cervix - clinicopathologic study using immunohistochemistry and mRNA in situ hybridization[J]. Gynecol Oncol ,1999, 72(3) :380-386.
  • 8Davidson B, Goldberg I, Kopoloric J, et al. MMP -2 and TIMP - 2 expression correlates with poor prognosis in cervical carcinoma——a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization [ J ]. Gynecol Oncol , 1999,73 ( 3 ) : 372-382.
  • 9欧阳运薇,彭芝兰,姚先莹,刘珊玲,何跃东.基质金属蛋白酶-2和-9在宫颈癌的表达及其相关性研究[J].四川大学学报(医学版),2004,35(3):330-333. 被引量:18
  • 10连丽娟 刘彤华 刘炽明.林巧稚妇科肿瘤学[M].北京:人民卫生出版社,2001.209.

二级参考文献11

  • 1[3]Garzetti GG,Ciavattini A,Lucarini G,et al.Vascular endothelial growth factor expression as a prognostic index in serous ovarian cystoadenocarcinoma. Gynecol Oncol,1999,73(3):396-401.
  • 2[5]Folkman J.What is the evidence that tumors are angiogenesis dependent.Nat Cancer Inst, 1990,82(1):4-7.
  • 3[1]Weidner N.Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 1995,147(1):9-19.
  • 4[2]Kodama J,Seki N,Tokumo K,et al. Vascular endothelial growth factor is implicated in early invasion in cervical cancer. Eur J Cancer, 1999,35(4):485-489.
  • 5Johansson N,Ahonen M,kahanv M.Matrix metalloproteinases in tumor invasion.Cell Mol Life Sci,2000;57(1):5.
  • 6Curran S,Murray GI.Matrix metalloproteinases in tumor invasion and metastasis.J Pathol,1999;189(3):300.
  • 7Talvensaari A,Apaja-Sarkkinen M,Hiyhtya M, et al.Martrix Metalloproteinases 2 immunoactive Protein Appears Early in Cervical Epithelial Dedifferentiation.Gynecol Oncol,1999;72:306.
  • 8Kawano N,Osawa H, Ito T, et al.Expression of Gelatinase A,Tissue Inhibitor of Metalloproteinases-2,Matrilysin,and Trypsin(ogen) in Lung Neoplasms: An Immunohistochemical Study. Human Pathol,1997;28(5):614.
  • 9Davidson B,Goldberg I,Kopoloric J,et al.Expresssion of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.Gynecol Oncol,1999;72:380.
  • 10Davidson B, Goldberg I, Kopolovic J, et al.MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma-a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.Gynecol Oncol,1999;73:372.

共引文献24

同被引文献63

引证文献6

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部